FDA approves HIV prevention drug taken as twice-yearly injection

cbsnews.com/news/hiv-prevention-drug-lenacapavir-yeztugo-approved-fda

The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.
The drug, called Yeztugo from company Gilead Sciences, was approved Wednesday based on data from clinical trials that showed 99.9% of participants who received it remained…

This story appeared on cbsnews.com, 2025-06-18 20:31:57.
The Entire Business World on a Single Page. Free to Use →